Search Results - Thomas Trolle

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    782-H Effects of an AI generated personalized neopeptide-based immunotherapy, EVX-01, in combination with pembrolizumab in patients with metastatic melanoma: a clinical trial updat... by Paolo A Ascierto, Georgina V Long, Michael Chisamore, Paola Queirolo, Adnan Khattak, Anders Jespersen, Daniela Kleine-Kohlbrecher, Nadia Viborg, Mads Lausen, Stine F Thorsen, Thomas Trolle

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  2. 2

    623 AI-designed personalized neoantigen vaccine, EVX-02, induces robust T-cell responses in melanoma patients by Anders Jespersen, Daniela Kleine-Kohlbrecher, Nadia Viborg, Mads Lausen, Thomas Trolle, Michail A Pavlidis, Nikolas H Thuesen, Christian Garde, Thomas S Jepsen, Britt W Lauenborg, Birgitte Rønø

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  3. 3

    DNA based neoepitope vaccination induces tumor control in syngeneic mouse models by Nadia Viborg, Michail Angelos Pavlidis, Marina Barrio-Calvo, Stine Friis, Thomas Trolle, Anders Bundgaard Sørensen, Christian Bahne Thygesen, Søren Vester Kofoed, Daniela Kleine-Kohlbrecher, Sine Reker Hadrup, Birgitte Rønø

    Published in npj Vaccines (2023-05-01)
    Get full text
    Article


  4. 4

    Endogenous viral elements constitute a complementary source of antigens for personalized cancer vaccines by Christian Garde, Michail A. Pavlidis, Pablo Garces, Emma J. Lange, Sri H. Ramarathinam, Mateo Sokač, Kirti Pandey, Pouya Faridi, Johanne Ahrenfeldt, Shanzou Chung, Stine Friis, Daniela Kleine-Kohlbrecher, Nicolai J. Birkbak, Jens V. Kringelum, Birgitte Rønø, Anthony W. Purcell, Thomas Trolle

    Published in npj Vaccines (2025-03-01)
    Get full text
    Article


Search Tools: